You can provide the best care possible inside the four walls of your hospital, but if your patients can’t afford their prescriptions after you discharge them, the system isn’t working. The post The Cost of Medication Non-Adherence — How Hospitals Can Close the Gap through Better Communication appeared first on MedCity News.
By DAVID INTROCASO After having worked in DC for sixteen years, in 2013 I created The Healthcare Policy Podcast. The title was in part intended to be sarcastic because healthcare policymaking in DC is very narrowly drawn. Consequently, healthcare delivery is excessively commodified, reductionistic and financialized or in sum anachronistic and ironically lacking purchase. If the…
The FDA clinical hold covers two Phase 3 studies for nexiguran ziclumeran, or nex-z, an experimental gene-editing therapy for transthyretin amyloidosis. Nex-z uses the CRISPR gene-editing technology to inactivate the gene that codes for the protein driving this rare disease. The post Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a…
An investigation into cosmetic surgery chains by KFF Health News and NBC News has prompted consumer warnings from industry groups representing plastic surgeons and a call for more transparency around physician disciplinary actions in California. The American Society of Plastic Surgeons, which represents 12,000 doctors, is now warning patients to “do their homework” before getting…
CIO Yeman Collier, Artisight CEO Andrew Gostine, M.D., M.B.A, discuss building on three initial use cases for Smart Hospital Platform
The FDA approved Novocure medical device Optune Luna as a treatment for advanced cases of non-small cell lung cancer. The wearable technology delivers electrical fields that kill cancer cells. The post Wearable Tumor-Zapping Medical Device Wins FDA Approval for Lung Cancer appeared first on MedCity News.
Panelists at University of Pennsylvania discuss policy recommendations that could advance integrated coverage and care for people eligible for both Medicare and Medicaid
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health News’ “What the Health?” She previously spent more than a decade reporting on the federal government, most recently covering surprise medical bills, drug pricing reform, and other health policy debates…
Michele Andrews had been seeing her internist in Northampton, Massachusetts, a small city two hours west of Boston, for about 10 years. She was happy with the care, though she started to notice it was becoming harder to get an appointment. “You’d call and you’re talking about weeks to a month,” Andrews said. That’s not…
Ventyx Biosciences’ lead program, an oral small molecule inhibitor of NLRP3, has encouraging clinical data from separate mid-stage tests in cardiovascular disease and Parkinson’s disease. Eli Lilly said Ventyx’s pipeline has potential applications in cardiometabolic health, neurodegeneration, and autoimmunity. The post Eli Lilly Boosts Its Immunology Drug Pipeline With $1.2B Ventyx Bio Acquisition appeared first…